Rhumbline Advisers Avid Bioservices, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 91,579 shares of CDMO stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,579

Previous 94,682 3.28%

Holding current value

$1.13 Million

Previous $676,000 54.14%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$6.7 - $12.45 $20,790 - $38,632	-3,103 Reduced 3.28%	91,579 $1.04 Million
Q2 2024 Aug 01, 2024	BUY	$6.34 - $9.28 $34,286 - $50,186	5,408 Added 6.06%	94,682 $676,000
Q1 2024 May 09, 2024	BUY	$5.86 - $8.79 $17,738 - $26,607	3,027 Added 3.51%	89,274 $598,000
Q4 2023 Feb 08, 2024	SELL	$4.64 - $9.56 $282,524 - $582,098	-60,889 Reduced 41.38%	86,247 $560,000
Q3 2023 Nov 09, 2023	SELL	$9.4 - $14.04 $3,120 - $4,661	-332 Reduced 0.23%	147,136 $1.39 Million
Q2 2023 Aug 08, 2023	SELL	$12.96 - $20.93 $453,107 - $731,754	-34,962 Reduced 19.16%	147,468 $2.06 Million
Q1 2023 May 11, 2023	BUY	$13.48 - $18.79 $138,870 - $193,574	10,302 Added 5.99%	182,430 $3.42 Million
Q4 2022 Feb 14, 2023	BUY	$12.61 - $18.74 $56,908 - $84,573	4,513 Added 2.69%	172,128 $2.37 Million
Q3 2022 Nov 10, 2022	BUY	$15.33 - $20.36 $84,974 - $112,855	5,543 Added 3.42%	167,615 $3.21 Million
Q2 2022 Aug 11, 2022	BUY	$11.63 - $21.55 $519,116 - $961,905	44,636 Added 38.01%	162,072 $2.47 Million
Q1 2022 May 12, 2022	SELL	$16.63 - $27.73 $425,212 - $709,028	-25,569 Reduced 17.88%	117,436 $2.39 Million
Q4 2021 Feb 10, 2022	BUY	$20.7 - $34.18 $1.61 Million - $2.66 Million	77,823 Added 119.39%	143,005 $4.17 Million
Q3 2021 Nov 12, 2021	BUY	$19.05 - $28.32 $39,738 - $59,075	2,086 Added 3.31%	65,182 $1.41 Million
Q2 2021 Aug 05, 2021	SELL	$18.93 - $25.65 $79,960 - $108,345	-4,224 Reduced 6.27%	63,096 $1.62 Million
Q1 2021 May 06, 2021	SELL	$11.86 - $21.77 $34,631 - $63,568	-2,920 Reduced 4.16%	67,320 $1.23 Million
Q4 2020 Feb 10, 2021	BUY	$7.25 - $11.76 $31,414 - $50,956	4,333 Added 6.57%	70,240 $811,000
Q3 2020 Nov 12, 2020	SELL	$6.53 - $8.6 $60,500 - $79,679	-9,265 Reduced 12.33%	65,907 $502,000
Q2 2020 Aug 13, 2020	BUY	$4.11 - $6.78 $15,979 - $26,360	3,888 Added 5.45%	75,172 $494,000
Q1 2020 May 06, 2020	BUY	$3.15 - $7.39 $891 - $2,091	283 Added 0.4%	71,284 $364,000
Q4 2019 Feb 05, 2020	BUY	$5.01 - $8.16 $1,568 - $2,554	313 Added 0.44%	71,001 $545,000
Q3 2019 Oct 23, 2019	BUY	$5.07 - $7.08 $466 - $651	92 Added 0.13%	70,688 $375,000
Q2 2019 Aug 14, 2019	BUY	$3.43 - $5.6 $19,876 - $32,451	5,795 Added 8.94%	70,596 $395,000
Q1 2019 May 01, 2019	SELL	$3.56 - $4.82 $7,298 - $9,881	-2,050 Reduced 3.07%	64,801 $275,000
Q4 2018 Jan 31, 2019	BUY	$4.04 - $6.75 $93,303 - $155,891	23,095 Added 52.78%	66,851 $274,000
Q3 2018 Nov 07, 2018	SELL	$4.28 - $7.32 $2,859 - $4,889	-668 Reduced 1.5%	43,756 $300,000
Q2 2018 Aug 06, 2018	BUY	$3.1 - $3.93 $137,714 - $174,586	44,424 New	44,424 $174,000

Others Institutions Holding CDMO

# of Institutions

183

Shares Held

67.8M

Call Options Held

89.9K

Put Options Held

118K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $765M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Avid Bioservices, Inc. Transaction History